首页> 美国卫生研究院文献>other >Is chemotherapy necessary for premenopausal women with lower-risk node-positive endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

【2h】

Is chemotherapy necessary for premenopausal women with lower-risk node-positive endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

机译：低危节点阳性内分泌反应性乳腺癌的绝经前妇女是否需要化疗？国际乳腺癌研究组试验11-93的10年更新

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionInternational Breast Cancer Study Group (IBCSG) Trial 11-93 is the largest trial evaluating the role of the addition of chemotherapy to ovarian function suppress/ablation (OFS) and tamoxifen in premenopausal patients with endocrine-responsive early breast cancer.

机译：简介国际乳腺癌研究小组（IBCSG）试验11-93是评估对绝经前内分泌敏感的早期乳腺癌患者卵巢功能抑制/消融（OFS）和他莫昔芬的化疗作用的最大试验。

著录项

期刊名称 other
作者
Beat Thürlimann; Karen N. Price; Richard D. Gelber; Stig B. Holmberg; Diana Crivellari; Marco Colleoni; John Collins; John F. Forbes; Monica Castiglione-Gertsch; Alan S. Coates; Aron Goldhirsch;
展开▼
作者单位

展开▼
年(卷),期 -1(113),1
年度 -1
页码 137–144
总页数 13
原文格式 PDF
正文语种
中图分类
关键词
breast cancer estrogen receptor goserelin ovarian ablation ovarian function suppression tamoxifen;

机译：乳腺癌;雌激素受体;戈舍瑞林;卵巢消融;卵巢功能抑制;他莫昔芬;
入库时间 2022-08-21 11:32:15

相似文献

外文文献
中文文献
专利

1. Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93. [J] . Thurlimann B, Price KN, Gelber RD, Breast cancer research and treatment. . 2009,第1期

机译：低危节点阳性，内分泌反应性乳腺癌的绝经前妇女是否需要化疗？国际乳腺癌研究小组试验11-93的10年更新。
2. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. [J] . Pagani O, Gelber S, Simoncini E Breast cancer research and treatment. . 2009,第3期

机译：对于高度内分泌反应性，淋巴结阳性的乳腺癌，接受内分泌治疗的绝经后妇女是否有益于辅助化疗？国际乳腺癌研究小组试验VII和12-93。
3. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. [J] . Colleoni M, Gelber S, Goldhirsch A, Journal of Clinical Oncology . 2006,第9期

机译：佐剂化疗后伴淋巴结阳性乳腺癌前进剂化疗：国际乳腺癌研究组试验13-93。
4. Association of bone mineral density and mammographic breast density in premenopausal and postmenopausal Malaysian women: Study on women with and without breast cancer [C] . Norhayati Mohd Zain, Vengkatha Priya Seriramulu, Kanaga Kumari Chelliah, International Conference on Bio-engineering for Smart Technologies . 2016

机译：绝经前和绝经后马来西亚女性的骨矿物质密度与乳房X线照片乳房密度的关系：有无乳腺癌的女性研究
5. The association between breastfeeding and the incidence of premenopausal breast cancer: Modification by breast cancer hormone receptor status. [D] . Heneghan, Maureen K. 2011

机译：母乳喂养与绝经前乳腺癌发生率之间的关联：乳腺癌激素受体状态的改变。
6. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93 [O] . Olivia Pagani, Shari Gelber, Edda Simoncini, -1

机译：对于高度内分泌反应性淋巴结阳性的乳腺癌接受内分泌治疗的绝经后妇女辅助化疗是否有益？国际乳腺癌研究小组第VII和12-93号试验
7. Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-Year update of International Breast Cancer Study Group Trial 11-93 [O] . Thürlimann, Beat, Price, Karen N., Goldhirsch, Aron, 2009

机译：低危节点阳性，内分泌反应性乳腺癌的绝经前妇女是否需要化疗？国际乳腺癌研究组试验11-93的10年更新

Is chemotherapy necessary for premenopausal women with lower-risk node-positive endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93

摘要

著录项

相似文献

相关主题

期刊订阅